Regeneron NAICS Code

About Regeneron

Regeneron, legally known as Regeneron Pharmaceuticals Inc., is a biotechnology company based in Eastview, New York. Founded and led by physician-scientists, the company specializes in inventing, developing, and commercializing life-transforming medicines for patients with serious diseases. Regeneron's portfolio includes treatments for eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, and infectious diseases. The company utilizes proprietary technologies such as VelociSuite® and the Regeneron Genetics Center® to accelerate drug development and identify innovative targets for disease treatment. Regeneron's leadership team includes Nobel Laureates and members of the National Academy of Sciences.

Primary NAICS Classification

Revenue Breakdown by NAICS

Estimated revenue distribution across industry classifications:

Core Offerings

• •Bispecific Antibody Development
• •Therapeutic Product Commercialization
• •Biotechnology Research and Development
• •Infectious Disease Medicine Development
• •Pharmaceutical Manufacturing
• •Clinical Trial Execution
• •Allergic and Inflammatory Disease Medicine Development
• •Rare Disease Medicine Development
• •Therapeutic Product Development
• •Eye Disease Medicine Development
• •Antibody Engineering and Production
• •Hematologic Condition Medicine Development
• •Cancer Medicine Development
• •Neurological Disease Medicine Development
• •Cardiovascular and Metabolic Disease Medicine Development

Industry Classification

Technologies

Code Crosswalks